Atropine 0.05% Ophthalmic Drops
Atropine 0.05% Ophthalmic Drops are an eye drop used to treat myopia, or nearsightedness. This medication works by blocking the receptors in the eyes that make vision more blurred at near distances, which in turn helps reduce the amount of nearsightedness and improve vision.
Controlled substances must be E-Prescribed. Visit your Tutorials tab to learn how to prescribe.
Formula Information
Atropine 0.05% Ophthalmic Drops is an effective formulation for treating myopia, also known as nearsightedness. This formulation is specifically designed to improve distant vision by slowing the progression of myopia or even possibly reversing the condition. It works by blocking the muscle receptors in the eye, reducing the amount of accommodation, or focusing power, that the eye requires. It has proven to be more successful than other treatments, such as wearing glasses or contact lenses. By using Atropine 0.05% Ophthalmic Drops, doctors can reduce the amount of myopia progression in nearsighted patients and help them achieve better clarity in vision. If you have any questions regarding this formulation, do not hesitate to reach out to us.
Drug Interactions
Atropine 0.05% Ophthalmic Drops are an eye drop used to treat myopia, or nearsightedness. This medication works by blocking the receptors in the eyes that make vision more blurred at near distances, which in turn helps reduce the amount of nearsightedness and improve vision.
How Does it Work
Atropine 0.05% Ophthalmic Drops are a topical agent used for the treatment of myopia. Myopia, or nearsightedness, occurs when the eye is unable to focus clearly on distant objects. Atropine 0.05% Ophthalmic Drops works by relaxing the focusing muscles of the eye, allowing light to spread out evenly over the back of the eye, which in turn helps reduce myopic refractive errors. Atropine 0.05% Ophthalmic Drops are administered once a day for a period of two weeks and then stopped for two weeks before being resumed. The effectiveness of Atropine 0.05% Ophthalmic Drops has been found to be greatest in patients younger than 18 years of age, with a marked decrease in myopia progression, especially in the first four to six weeks after initial treatment. Due to its reversible action, Atropine 0.05% Ophthalmic Drops can be used as a long-term therapy and side effects are typically mild and reversible. Common side effects may include burning, redness and discomfort in the eyes, headaches, and drooping of the eyelids. Since Atropine 0.05% Ophthalmic Drops may cause dilation of the pupil, patients may experience a decrease in sensitivity to light and may have difficulty focusing in bright lighting. It is important to note that Atropine 0.05% Ophthalmic Drops are not a one-time cure for myopia and their effectiveness may diminish over time. Therefore, your patient should be carefully monitored for any changes in vision and may need to be switched to a different course of treatment in the future.
Other Uses
Atropine 0.05% Ophthalmic Drops can also be used as a therapeutic treatment for cycloplegia, when the ciliary muscles of the eye become spastic and the pupil cannot accommodate to changing light conditions, as well as a prophylaxis for posterior synechiae, which is the adhesion of the lens and the iris that can lead to the formation of cataracts. Additionally, it can be prescribed to reduce the risk of developing amblyopia from eye alignment disorders, as well as to obtain a cycloplegic refraction that allows for a more accurate prescripion for corrective lenses.
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.